← Back to Search

Behavioral Intervention

BUILT Family Lifestyle Program for ADHD (BUILT Trial)

N/A
Recruiting
Led By Eduardo E Bustamante, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (within 2-weeks of intervention start date), posttest (within 2-weeks of intervention end date)
Awards & highlights

BUILT Trial Summary

This trial is designed to study a new program called BUILT that is designed to help families adopt healthy food, sleep, and exercise routines that will optimize child focus, attention, and behavior.

Who is the study for?
The BUILT program is for boys and girls aged 6 to 12 with ADHD, who are enrolled in Chicago Park District programs. They must be able to do aerobic activities and have a parent willing to attend an orientation session.Check my eligibility
What is being tested?
BUILT aims to improve children's focus, attention, and behavior through better food, sleep, and exercise routines over an 8-week course. It will measure changes in health behaviors, mental health (especially ADHD symptoms), physical literacy, and family dynamics.See study design
What are the potential side effects?
Since BUILT focuses on lifestyle improvements rather than medication or medical procedures, no direct side effects are expected from the program itself.

BUILT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (within 2-weeks of intervention start date), posttest (within 2-weeks of intervention end date)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (within 2-weeks of intervention start date), posttest (within 2-weeks of intervention end date) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Diet Quality at Posttest
Change from Baseline Moderate-Vigorous Physical Activity at Posttest
Change from Baseline Recreational Screen Time Quantity at Posttest
+1 more
Secondary outcome measures
Change from Baseline Child Resilience at Posttest
Change from Baseline Combined ADHD Symptoms at Posttest
Change from Baseline Executive Function at Posttest
+7 more

BUILT Trial Design

1Treatment groups
Experimental Treatment
Group I: BUILT StudyExperimental Treatment1 Intervention
One group receives the intervention.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
611 Previous Clinical Trials
1,560,249 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
530 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
UIC Center for Health Equity Research (CHER)UNKNOWN
UIC Chicago Partnership for Health Promotion (CPHP)UNKNOWN

Media Library

Be Unstoppable in Life Together (BUILT) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05464056 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: BUILT Study
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: Be Unstoppable in Life Together (BUILT) Highlights & Side Effects. Trial Name: NCT05464056 — N/A
Be Unstoppable in Life Together (BUILT) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05464056 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to join this research endeavor at the present time?

"This clinical trial, which was initially made available on July 15th 2022 is currently searching for patients. The most recent update of the study occurred one day prior."

Answered by AI

Are there any restrictions on who can take part in this experimental investigation?

"To be accepted into this clinical trial, participants must have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and are required to fit within the age range of 6-12 years old. Currently, 316 individuals can take part in this study."

Answered by AI

Is this research initiative accessible to adults?

"In order to participate in this trial, individuals must be within the bracket of 6-12 years old. For minors and seniors, there are respectively 108 trials for those below 18 and 35 available studies for persons over 65 years of age."

Answered by AI

What is the uppermost number of participants for this experiment?

"That is accurate. As per the clinicaltrials.gov website, this clinical trial was initially posted on July 15th 2022 and updated as recently as July 14th 2022 to reflect its need for 316 patients at one location."

Answered by AI

What objectives has this experiment been designed to accomplish?

"The primary outcome of this clinical experiment, which will be monitored between the baseline (up to two weeks after treatment commencement) and post-test (within two weeks subsequent to completion of therapy), is a change in recreational screen time quantity. Secondary outcomes encompass changes in social capital - as evaluated by a ten item community collective efficacy questionnaire with five point Likert scale responses ranging from "strongly agree" to "strongly disagree", parent-child communication assessed through the Family Problem Solving Communication instrument's ten statement template scored on a 0 to 3 scale based off veracity, and combined ADHD symptoms - determined using the Disruptive Behavior Disorder"

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
Iowa
Illinois
How old are they?
18 - 65
What site did they apply to?
Chicago Park District
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
2

Why did patients apply to this trial?

66 years old and age ADHD has destroyed my life I left me homeless most of my life / unemployable a lot of times/.
PatientReceived 1 prior treatment
~115 spots leftby May 2025